Aristeia Capital’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Aristeia Capital’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-46,390	Closed	-$15.1K	–	413
2024 Q1	$15.1K	Hold	46,390	–	–	﹤0.01%	251
2023 Q4	$10.2K	Hold	46,390	–	–	﹤0.01%	174
2023 Q3	$8.58K	Hold	46,390	–	–	﹤0.01%	220
2023 Q2	$7.22K	Hold	46,390	–	–	﹤0.01%	251
2023 Q1	$3.32K	Hold	46,390	–	–	﹤0.01%	380
2022 Q4	$3.12K	Hold	46,390	–	–	﹤0.01%	500
2022 Q3	$3K	Hold	46,390	–	–	﹤0.01%	690
2022 Q2	$4K	Hold	46,390	–	–	﹤0.01%	689
2022 Q1	$16K	Buy	+46,390	New	+$21.1K	﹤0.01%	714

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Aristeia Capital's AONCW Position: Q2 2024 in Review

Aristeia Capital sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 46,390 shares — an estimated $15.1K sold.

Aristeia Capital first reported a position in AONCW in Q1 2022 and held it in 9 quarters. The position peaked at $16K in Q1 2022. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Aristeia Capital reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Aristeia Capital sold 46,390 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $15.1K.
Aristeia Capital first reported a position in American Oncology Network, Inc. Warrant in Q1 2022 and held it in 9 quarters.
Aristeia Capital's American Oncology Network, Inc. Warrant position peaked at $16K in Q1 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Aristeia Capital's 13F filing for Q2 2024, filed 14 Aug 2024.